Support for national pharmaceutical manufacturers should be given through state orders, Head of the parliamentary healthcare committee Olha Bohomolets has said.

"State orders for a period of three to five years could stimulate the development of national pharmaceutical producers. Then national producers will be ready to open new production lines, invest funds and create new jobs," she said in an interview with Interfax-Ukraine.

Bohomolets also said that Ukrainian pharmaceutical companies are businesses, which along with the creation of new jobs could develop and sell products aboard.

She said that in the near future Ukraine will not start producing innovative drugs, including drugs for treating rare diseases.

She said that transparent state procurement should begin over the supply of innovation drugs to the country, while Ukrainian pharmaceutical companies could produce other drugs, for example, generics.